That’s 100% it. It’s a long long road but plenty changes in a...

That’s a really good point donor locations and immunogenicity - I think you might be right. I’m not sure where the dermis stands but it is CERTAINLY an improvement over the liver (which has a very very aggressive immune response).

Obviously it won’t remove the immune response factor entirely, but I’m sure it’s a benefit.

and regarding revenue stream … if we end up part of the diabetes cure, 1/8 people worldwide will have diabetes by 2045. Now, most are type 2, but ~15% of those would benefit from islet transplants. So if medicine can solve the other issues, imagine maybe 1 in every 50 people worldwide, being on the waiting list for slab of BTM and a dose of lab grown islets. That would be a HUGE revenue stream.

That’s 100% it. It’s a long long road but plenty changes in a few decades and there’s a lot of research going into this area. I feel like whichever solution medicine employs, diabetes could absolutely be cured within 30 years. I hope we’re part of the solution!

And as a POC, I have no knowledge here, but I’m absolutely sure that if we could show BTM vascularises well enough to make this islets more viable, it will have tangential applications - perhaps simply in the case of other transplants, strategically placing BTM. Not to mention it should partly strengthen our case in areas we already sell into.